Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Dec 23, 2014 (12 years ago)

Fluconazole Injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: Complaints of leaks due to an incomplete seal at the bag seam.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Fluconazole Injection, USP, 200 mg/100 mL (2 mg/mL), 100 mL Single-Dose INTRAVIA Container bag, packaged in 10 x 100 mL Single Dose INTRAVIA container bags per carton, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-6046-48, Product Code 2J1446.

Affected NDC 0338-6046-48

Compare with the code on your package — it is the most precise check available.

Drug: Fluconazole

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Fluconazole
NDC 00338-6046
200 mg/100mL Injection, Solution
Intravenous
Baxter Healthcare Company Rx
Recalling firm
Baxter Healthcare Corp.
NDC code
0338-6046-48
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0380-2015 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Fluconazole recalls

See all
Class III · Low risk

Fluconazole Injection

Superpotent Drug: lots out of specification for elevated sodium chloride and fluconazole assay.

Terminated Wrong potency / content Renaissance Lakewood, LLC D-1033-2018
Class III · Low risk

Fluconazole Injection

Failed Stability Specifications: lot out of specification for elevated water vapor.

Terminated Stability / shelf life Renaissance Lakewood, LLC NDC 36000-002-10 D-1032-2018
Class III · Low risk

Fluconazole Injection

Superpotent Drug and Failed Stability Specifications: lot out of specification for elevated sodium chloride and elevated water vapor.

Terminated Wrong potency / content Renaissance Lakewood, LLC NDC 36000-003-06 D-1031-2018
Class II · Moderate risk

Fluconazole Injection

Labeling: Label mix-up - A complaint was received of one bag of Fluconazole Injection, Iso-Osmotic Sodium Chloride Diluent, USP, 2mg/mL, 50 mL found within the package of 100 mL bags.

Terminated Labeling / mix-up Renaissance Lakewood, LLC NDC 36000-002-10 D-0696-2018

Other recalls by Baxter Healthcare Corp.

All 2014 recalls
Class I · High risk

Dextrose Injection

Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.

Ongoing Particulate / foreign matter Baxter Healthcare Corporation NDC 00338-0719-06 D-0850-2026
Class II · Moderate risk

Daptomycin

CGMP Deviations

Ongoing cGMP deviation Baxter Healthcare Corporation NDC 0338-0718-12 D-0821-2026